GTH 2026: Connected Science – Advanced Solutions

Abstract

Research into the molecular mechanisms of hereditary haemostatic disorders has provided significant insights into the fundamental mechanisms of the haemostatic system. Examples of such disorders include haemophilia A and von Willebrand disease. Meanwhile, findings from basic science research have enabled the development of new therapeutic approaches. One such approach is gene therapy for haemophilia.

Publication History

Article published online:
19 February 2026

• References

• 1 Miesbach W. Gene Therapy: Current Status and Future Directions. Hamostaseologie 2026; 46: 10-16
• 2 Abdelmageed A, Lisowski C, Becker-Gotot J. Immune Response Mechanisms in Haemophilia A. Hamostaseologie 2026; 46: 17-23
• 3 Brehm M. Structural Analysis of von Willebrand Factor. Hamostaseologie 2026; 46: 24-33
• 4 Yadegari H. Von Willebrand Factor at the Crossroads of Hemostasis and Inflammation. Hamostaseologie 2026; 46: 34-43
• 5 Reusswig F, Deppermann C. The Role of Platelets Beyond hemostasis. Hamostaseologie 2026; 46: 44-52
• 6 Feige T, Bosbach A, Krott K, Elvers M. Role of platelets in abdominal aortic aneurysm formation and progression: New aspects from experimental and clinical approaches. Hamostaseologie 2026; 46: 53-64
• 7 Pezeshkpoor B, Oldenburg J, Müller J. Thrombin Generation Assays: Possibilities and Limitations. Hamostaselogie 2026; 46: 65-70
• 8 Rühl H, Reda S. Management of Splanchnic Venous Thrombosis: An Update. Hamostaseologie 2026; 46: 71-77